STAAR Surgical Company STAA
NASDAQ
| 10/02/2026 | 07/03/2026 | 04/03/2026 | 01/02/2026 | 09/26/2025 | |
|---|---|---|---|---|---|
| Revenue | 42.36% | 51.30% | 4.03% | -23.72% | -32.42% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 42.36% | 51.30% | 4.03% | -23.72% | -32.42% |
| Cost of Revenue | 44.04% | 25.00% | -7.55% | -23.27% | -16.95% |
| Gross Profit | 41.76% | 61.68% | 8.10% | -23.86% | -36.60% |
| SG&A Expenses | -6.67% | -9.12% | -13.55% | -8.09% | -0.27% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.33% | -2.47% | -12.35% | -12.59% | -6.56% |
| Operating Income | 135.57% | 150.67% | 114.33% | -270.38% | -329.11% |
| Income Before Tax | 106.06% | 117.81% | 68.11% | -808.78% | -362.54% |
| Income Tax Expenses | 13.98% | 687.46% | -84.91% | -116.27% | -66.61% |
| Earnings from Continuing Operations | 100.55% | 104.03% | 70.41% | -298.10% | -542.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 100.55% | 104.03% | 70.41% | -298.10% | -542.54% |
| EBIT | 135.57% | 150.67% | 114.33% | -270.38% | -329.11% |
| EBITDA | 157.85% | 168.18% | 139.41% | -585.58% | -263.19% |
| EPS Basic | 100.34% | 103.91% | 70.55% | -296.76% | -540.46% |
| Normalized Basic EPS | 145.34% | 163.47% | 133.07% | -304.02% | -258.82% |
| EPS Diluted | 100.10% | 103.67% | 70.31% | -292.72% | -545.61% |
| Normalized Diluted EPS | 143.79% | 161.86% | 130.80% | -296.53% | -261.90% |
| Average Basic Shares Outstanding | 1.40% | 1.16% | 0.96% | 0.89% | 0.87% |
| Average Diluted Shares Outstanding | 2.48% | 2.45% | 1.30% | 0.74% | 0.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |